| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Chief Commercial Officer | Performance Stock Units | 7.74K | $1.01M | $131.07 | Feb 24, 2025 | Direct |
| Axsome Therapeutics, Inc. | Chief Commercial Officer | Restricted Stock Units | 7.74K | $1.01M | $131.07 | Feb 21, 2025 | Direct |
| Axsome Therapeutics, Inc. | Chief Commercial Officer | Employee Stock Option (Right to Buy) | 7.82K | Feb 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Feb 21, 2025 | 3 | $0 | 4 | Feb 25, 2025 | Chief Commercial Officer |
| AXSM | Axsome Therapeutics, Inc. | Oct 14, 2024 | 0 | $0 | 3 | Oct 24, 2024 | Chief Commercial Officer |